Abstract
Background/Objectives
An increase in fat mass is accompanied by a loss of muscle mass and function in chronic kidney disease. However, no studies in haemodialysis (HD) patients have investigated the relationship between fat mass and sarcopenia. The primary aim of this study is to assess the prevalence of sarcopenia, while the secondary aim is to verify the association between the fat mass percentage and SARC-F and SARC-F combined with calf circumference (SARC-F+CC) in elderly HD patients.
Subjects/Methods
A cross-sectional study enrolled 96 HD older patients (male, n = 66). SARC-F ≥4 is used to define the muscle function loss, whereas SARC-F ≥6 or SARC-F ≥11 (with the calf circumference added) are the thresholds to diagnose sarcopenia. The fat mass percentage is obtained using bioelectrical impedance analysis.
Results
We found that 37.5% had a risk of muscle function loss due to SARC-F ≥4, 21.8% risk of sarcopenia using the SARC-F ≥6, and when using CC, the prevalence of risk of sarcopenia increased to 41.6% according to SARC-F+CC ≥11. In addition, there was an association between adiposity and sarcopenia for SARC-F ≥6 (OR: 1.25, p= 0.028) and SARC-F+CC ≥11 (OR: 1.25, p= 0.0003), but not with muscle function loss (SARC-F ≥4).
Conclusion
In conclusion, we found that 37.5% of HD patients had a risk of muscle function loss and 21–41% presented sarcopenia, depending on the cut-off point used. In addition, higher adiposity was associated with an increased likelihood of having sarcopenia by 25%.
Similar content being viewed by others
References
Ziolkowski SL, Long J, Baker JF, Chertow GM, Leonard MB. Relative sarcopenia and mortality and the modifying effects of chronic kidney disease and adiposity. J Cachexia Sarcopenia Muscle 2019;10:338–46. https://doi.org/10.1002/jcsm.12396.
Moorthi RN, Avin KG. Clinical relevance of sarcopenia in chronic kidney disease. Curr Opin Nephrol Hypertens 2017;26:219–28. https://doi.org/10.1097/MNH.0000000000000318.
Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol 2018;14:513–37. https://doi.org/10.1038/s41574-018-0062-9.Sarcopenic.
Vincent HK, Raiser SN, Vincent KR. The aging musculoskeletal system and obesity-related considerations with exercise. Ageing Res Rev 2012;11:361–73. https://doi.org/10.1016/j.arr.2012.03.002.The.
Petroni ML, Caletti MT, Grave RD, Bazzocchi A, Aparisi Gómez MP, Marchesini G. Prevention and treatment of sarcopenic obesity in women. Nutrients 2019;11:1–24. https://doi.org/10.3390/nu11061302.
Wood J, Ward L, Sparrow M, King S. Utility of bioimpedance methods for the assessment of fat-free mass in adult outpatients with inflammatory bowel disease. Nutrition 2020;77:110833. https://doi.org/10.1016/j.nut.2020.110833.
Ida S, Kaneko R, Murata K. SARC-F for Screening of Sarcopenia Among Older Adults: A Meta-analysis of Screening Test Accuracy. J Am Med Dir Assoc 2018;19:685–9. https://doi.org/10.1016/j.jamda.2018.04.001.
Barbosa-Silva TG, Menezes AMB, Bielemann RM, Malmstrom TK, Gonzalez MC. Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice. J Am Med Dir Assoc 2016;17:1136–41. https://doi.org/10.1016/j.jamda.2016.08.004.
Yang M, Hu X, Xie L, Zhang L, Zhou J, Lin J, et al. Screening Sarcopenia in Community-Dwelling Older Adults: SARC-F vs SARC-F Combined With Calf Circumference (SARC-CalF). J Am Med Dir Assoc 2018;19:277.e1–277.e8. https://doi.org/10.1016/j.jamda.2017.12.016.
Chertow M, Lowrie G, Leboff S, Michael J, Lew L, Gonzalez J. Analysis in Maintenance With Bioelectrical Hemodialysis 1995:75–81.
Basile C, Vernaglione L, Di Iorio B, Bellizzi V, Chimienti D, Lomonte C, et al. Development and validation of bioimpedance analysis prediction equations for dry weight in hemodialysis patients. Clin J Am Soc Nephrol 2007;2:675–80. https://doi.org/10.2215/CJN.00240107.
Androga L, Sharma D, Amodu A, Abramowitz MK. Sarcopenia, Obesity, and Mortality in US Adults With and Without Chronic Kidney Disease. Kidney Int Reports 2017;2:201–11. https://doi.org/10.1016/j.ekir.2016.10.008.
Lipschitz DA. Screening for nutritional status in the elderly. Prim Care 1994;21:55–67.
WHO. Physical Status: The use and interpretation of anthropometry 1995.
Yamamoto S, Matsuzawa R, Harada M, Watanabe T, Shimoda T, Suzuki Y, et al. SARC-F Questionnaire: Rapid and Easy Tool for Identifying Physical Limitations in Hemodialysis Patients. JCSM Clin Reports 2019;4. https://doi.org/10.17987/jcsm-cr.v4i1.74.
Woo J, Leung J, Morley JE. Validating the SARC-F: A suitable community screening tool for sarcopenia? J Am Med Dir Assoc 2014;15:630–4. https://doi.org/10.1016/j.jamda.2014.04.021.
Sánchez-Rodríguez D, Marco E, Dávalos-Yerovi V. Translation and Validation of the Spanish Version of the SARC-F Questionnaire to Assess Sarcopenia in Older People. J Nutr Heal Aging 2019;23:518–524. https://doi.org/10.1007/s12603-019-1204-z.
D’alessandro C, Piccoli GB, Barsotti M, Tassi S, Giannese D, Morganti R, et al. Prevalence and correlates of sarcopenia among elderly CKD outpatients on tertiary care. Nutrients 2018;10:1–13. https://doi.org/10.3390/nu10121951.
Arango-Lopera VE, Arroyo P, Gutiérrez-Robledo LM, Perez-Zepeda MU, Cesari M. Mortality as an adverse outcome of sarcopenia. J Nutr Heal Aging 2013;17:259–62. https://doi.org/10.1007/s12603-012-0434-0.
Marini ACB, Perez DRS, Fleuri JA, Pimentel GD. SARC-F Is Better Correlated with Muscle Function Indicators Than Muscle Mass in Older Hemodialysis Patients. J Nutr Heal Aging 2020. https://doi.org/10.1007/s12603-020-1426-0.
Tian S, Xu Y. Association of sarcopenic obesity with the risk of all-cause mortality: A meta-analysis of prospective cohort studies. Geriatr Gerontol Int 2016;16:155–66. https://doi.org/10.1111/ggi.12579.
Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani CM. Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol 2020. https://doi.org/10.1007/s40620-020-00840-y.
Acknowledgements
A.C.B.M. would like to thank the Capes, Brazil. G.D.P. would like to The Brazilian National Council for Scientific and Technological Development (CNPq, Brazil, 312252/2019-6).
Author information
Authors and Affiliations
Contributions
A.C.B.M. and G.D.P. contributed to the study design. A.C.B.M. participated in the collection of data. A.C.B.M., R.S.F., and G.D.P. performed the literature search and discussed the paper. A.C.B.M., R.S.F., and G.D.P. wrote the manuscript. A.C.B.M., G.D.P. participated in critical discussion of data and reviewed the manuscript. All authors critically revised the manuscript, agree to be fully accountable for ensuring the integrity and accuracy of the work, and read and approved the final manuscript.
Corresponding author
Additional information
Conflict of Interest
All authors declare that they have no conflict of interest.
Financial disclosure statement
None declared.
Rights and permissions
About this article
Cite this article
Feitosa, R.S., Marini, A.C.B. & Pimentel, G.D. Association of Fat Mass with SARC-F in Older Patients Undergoing Haemodialysis. J Nutr Health Aging 26, 183–186 (2022). https://doi.org/10.1007/s12603-022-1737-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-022-1737-4